Similar articles

• Advances in the genetics of progressive myoclonus epilepsy.

  Delgado-Escueta AV, Ganesh S, Yamakawa K. Delgado-Escueta AV, et al. Am J Med Genet. 2001 Summer;106(2):129-38. doi: 10.1002/ajmg.1575. Am J Med Genet. 2001. PMID: 11579433 Review.
• On the road to tractability: the current biochemical understanding of progressive myoclonus epilepsies.

  Lohi H, Chan EM, Scherer SW, Minassian BA. Lohi H, et al. Adv Neurol. 2006;97:399-415. Adv Neurol. 2006. PMID: 16383151 Review. No abstract available.
• Mutations in NHLRC1 cause progressive myoclonus epilepsy.

  Chan EM, Young EJ, Ianzano L, Munteanu I, Zhao X, Christopoulos CC, Avanzini G, Elia M, Ackerley CA, Jovic NJ, Bohlega S, Andermann E, Rouleau GA, Delgado-Escueta AV, Minassian BA, Scherer SW. Chan EM, et al. Nat Genet. 2003 Oct;35(2):125-7. doi: 10.1038/ng1238. Epub 2003 Sep 7. Nat Genet. 2003. PMID: 12958597
• Neuronal survival in epilepsy: to die or not to die?

  Ganesh S, Singh S. Ganesh S, et al. J Biosci. 2005 Dec;30(5):561-6. doi: 10.1007/BF02703553. J Biosci. 2005. PMID: 16388127 Review. No abstract available.
• Generation of a human induced pluripotent stem cell line (UEFi004-A) from a patient with progressive myoclonic epilepsy type 1 (EPM1).

  Singh S, Plotnikova L, Karvonen K, Ryytty S, Hyppönen J, Kälviäinen R, Hämäläinen RH. Singh S, et al. Stem Cell Res. 2023 Dec;73:103248. doi: 10.1016/j.scr.2023.103248. Epub 2023 Nov 7. Stem Cell Res. 2023. PMID: 37951142